NBTX Stock: Price, Earnings History and SEC Filings
Nanobiotix S.A. (NBTX) last traded at $31.37, down 7.19% on the latest session and up 0.7% over the past month.
Price data from Yahoo Finance, as of Oct 30, 2026. May be delayed.
NBTX earnings history
Earnings history is not available right now.
Latest SEC filings for NBTX
Insider filing activity
NBTX insiders filed 0 Form 4 reports in the last 90 days. A Form 4 is how directors and executives disclose purchases, sales and grants of company stock. See the individual filings on SEC EDGAR. Many Form 4 filings are routine, such as scheduled sales or option exercises, so check each filing before drawing a conclusion.
Source: SEC EDGAR.
NBTX news
- Nanobiotix: The Phase 3 May Come Later, And Lenders Get Paid FirstOct 30, 2026 · seekingalpha.com
- Nanobiotix (ENXTPA:NANO) Could Be 46% Undervalued As Melanoma Trial Results LandOct 26, 2026 · finance.yahoo.com
- Nanobiotix stock gains on positive melanoma trial dataOct 26, 2026 · finance.yahoo.com
- NANOBIOTIX Announces Final Data from Phase 1 Study Evaluating JNJ-1900 (NBTXR3) With Immune Checkpoint Inhibitors as a 2L+ Therapy in Anti-PD-1-Resistant Primary Cutaneous MelanomaOct 24, 2026 · finance.yahoo.com
- Voting Rights and Shares Capital of the CompanyOct 20, 2026 · finance.yahoo.com
About Nanobiotix S.A.
Nanobiotix S.A. (NBTX) is a US-listed public company on Nasdaq. The SEC classifies its business as Pharmaceutical Preparations. It is incorporated in France. Its fiscal year ends in December.